Arteris, Inc. (NASDAQ:AIP - Get Free Report)'s share price reached a new 52-week high during mid-day trading on Tuesday . The stock traded as high as $14.29 and last traded at $13.14, with a volume of 10560515 shares traded. The stock had previously closed at $9.45.
Analyst Ratings Changes
A number of analysts have weighed in on the company. Rosenblatt Securities restated a "buy" rating and issued a $14.00 price target on shares of Arteris in a research note on Wednesday, May 21st. TD Cowen increased their price target on shares of Arteris from $12.00 to $15.00 and gave the company a "buy" rating in a research note on Wednesday.
View Our Latest Stock Report on AIP
Arteris Stock Performance
The firm's 50-day simple moving average is $9.12 and its 200 day simple moving average is $8.39. The company has a market capitalization of $402.15 million, a PE ratio of -11.76 and a beta of 1.45.
Insiders Place Their Bets
In other news, COO Laurent R. Moll sold 34,400 shares of the company's stock in a transaction on Tuesday, August 5th. The shares were sold at an average price of $13.57, for a total value of $466,808.00. Following the completion of the transaction, the chief operating officer directly owned 442,071 shares in the company, valued at approximately $5,998,903.47. This represents a 7.22% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. Also, CFO Nicholas B. Hawkins sold 11,276 shares of the stock in a transaction that occurred on Tuesday, August 5th. The stock was sold at an average price of $13.15, for a total value of $148,279.40. Following the transaction, the chief financial officer directly owned 107,996 shares in the company, valued at approximately $1,420,147.40. This represents a 9.45% decrease in their position. The disclosure for this sale can be found here. In the last three months, insiders sold 456,043 shares of company stock valued at $5,484,028. 29.10% of the stock is currently owned by corporate insiders.
Institutional Trading of Arteris
Institutional investors and hedge funds have recently modified their holdings of the business. Cambridge Investment Research Advisors Inc. bought a new position in shares of Arteris during the first quarter worth about $95,000. G2 Investment Partners Management LLC bought a new position in Arteris in the 4th quarter valued at about $2,799,000. BNP Paribas Financial Markets bought a new stake in shares of Arteris during the 4th quarter worth about $214,000. Two Sigma Advisers LP boosted its holdings in shares of Arteris by 82.9% in the fourth quarter. Two Sigma Advisers LP now owns 23,600 shares of the company's stock valued at $240,000 after acquiring an additional 10,700 shares in the last quarter. Finally, EAM Investors LLC acquired a new position in shares of Arteris during the fourth quarter valued at approximately $983,000. 64.36% of the stock is owned by institutional investors and hedge funds.
About Arteris
(
Get Free Report)
Arteris, Inc provides semiconductor interconnect intellectual property (IP) and System-on-Chip (Soc) Integration Automation software solutions (SIA) in the Americas, the Asia Pacific, Europe, and the Middle East. The company develops, licenses, and supports the on-chip interconnect fabric technology used in Soc designs and Network-on-Chip (NoC) interconnect IP.
Featured Stories
Before you consider Arteris, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Arteris wasn't on the list.
While Arteris currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Enter your email address and we'll send you MarketBeat's list of ten stocks that are set to soar in Fall 2025, despite the threat of tariffs and other economic uncertainty. These ten stocks are incredibly resilient and are likely to thrive in any economic environment.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.